Neuritis nervi optici;Erster hinweis auf eine multiple sklerose? Aktuelle diagnostische und therapeutische strategien

Ophthalmologe

Volumn 98, Issue 3, 2001, Pages 310-319

  Kiefer, G ^a   Rieckmann, P ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL FEATURE; DEMYELINATION; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; IMMUNOMODULATION; INFECTION; MULTIPLE SCLEROSIS; NEURITIS; OPHTHALMOSCOPY; OPTIC NERVE DISEASE; PAPILLITIS; PROGNOSIS; SARCOIDOSIS; ADOLESCENT; ADULT; CHILD; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NEURITIS; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK FACTOR; TIME;

ANTIINFLAMMATORY AGENT; METHYLPREDNISOLONE; PLACEBO; PREDNISONE;

ADOLESCENT; ADULT; ANTI-INFLAMMATORY AGENTS; CHILD; DIAGNOSIS, DIFFERENTIAL; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; METHYLPREDNISOLONE; MIDDLE AGED; MULTIPLE SCLEROSIS; OPTIC NEURITIS; PLACEBOS; PREDNISONE; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS; RISK FACTORS; TIME FACTORS;

EID: 0035081683     PISSN: 0941293X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003470170169     Document Type: Article

References (21)

1. Brain MRI in acute optic neuritis
2. The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis
3. Steroids for multiple sclerosis and optic neuritis: A meta-analysis of randomized controlled clinical trials
4. Interferon beta 1a (Rebif) in patients with acute neurological syndromes suggestive of multiple sclerosis: A multi-center, randomized, double-blind, placebo-controlled study
5. Movement phosphenes in optic neuritis: A new clinical sign
6. Acute unilateral papillits versus retrobulbar neuritis: Relation to multiple sclerosis
7. Orbital pain in optic neuritis and anterior ischemic optic neuropathy
8. Visual field defects in optic neuritis and anterior ischemic optic neuropathy: Distinctive features
9. Long-term follow-up of isolated optic neuritis: The risk of developing multiple sclerosis, its outcome, and the prognostic role of paraclinical tests
10. The 5-year risk of MS after optic neuritis
11. Interaction between HLA-DR2 and abnormal brain MRI in optic neuritis and early MS. Optic Neuritis Study Group
12. The effect of intramuscular interferon beta-1a treatment initiated at the time of a first acute clinical demyelinating event on the rate of development of clinically definite multiple sclerosis
13. Practice parameter: The role of corticosteroids in the management of acute monosymptomatic optic neuritis
14. The significance of brain magnetic resonance imaging abnormalities at presentation with clinically isolated syndromes suggestive of multiple sclerosis
15. Immunmodulatorische stufentherapie der multiplen sklerose
16. The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up
17. Prognostic indicators in multiple sclerosis
18. Escalating immunotherapy of multiple sclerosis
19. Optic neuritis and ischemic optic neuropathy. Overlapping clinical profiles
20. A randomized, controlled trial of oral high-dose methylprednisolone in acute optic neuritis